【摘要】 目的:编制终末期肝病症状评估量表，并检验其信效度。方法:以症状体验模型为理论基础，根据文献回顾、半结构化访谈建立初始条目池，经过德尔菲法专家函询，形成初始量表。选取河北省某三级甲等医院消化内科住院治疗的334例终末期肝病病人进行临床调查，检验量表的信效度。结果:最终形成的终末期肝病症状评估量表包括7个维度，共23个条目。量表条目水平的内容效度指数为0.833～1.000，量表水平的内容效度指数为0.971。探索性因子分析共提取7个公因子，累计方差贡献率为62.556%；验证性因子分析结果显示，量表的修正模型拟合良好。量表的Cronbach’s α系数为0.859，折半信度为0.827，重测信度为0.848。结论:终末期肝病症状评估量表具有良好的信效度，可以用于评估终末期肝病病人的症状负担。更多还原

【Abstract】 Objective:To develop the symptom assessment scale for patients with end-stage liver disease,and to test its reliability and validity. Methods:Based on the symptom experience model,the initial item pool was established according to the methods of literature review and semi-structured interview. After Delphi expert consultation,the initial scale was formed. A total of 334 patients with end-stage liver disease who were hospitalized in the department of gastroenterology of a tertiary grade A hospital in Hebei province were selected to test the reliability and validity. Results:The final version of symptom assessment scale for patients with end-stage liver disease included 7 dimensions,involving 23 items. The item-content validity index(I-CVI) ranged from 0. 833 to 1. 000,and scale-content validity index(S-CVI) was 0. 971. The exploratory factor analysis(EFA) extracted 7 common factors,and the cumulative variance contribution rate was 62. 556%. Confirmatory factor analysis showed that the model fitted well. The Cronbach’s α coefficient of the scale was 0. 859,the split-half reliability was 0. 827,and the test-retest reliability was 0. 848. Conclusion:The symptom assessment scale for patients with end-stage liver disease had good reliability and validity,which could be used to evaluate the symptom burden of patients with end-stage liver disease.更多还原